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The PRICKLE1 (Prickle Planar Cell Polarity Protein 1-MIM 608500) gene is involved in different
phases of human development. The related diseases include autosomal recessive progressive
myoclonus epilepsy - ataxia syndrome, neural tube defects associated with heterozygous muta-
tions, agenesis of corpus callosum, polymicrogyria, and autistic spectrum disorder. Reported
here is a young boy with a new variant (NM_153026.2:c.820G>A, p.Ala274Thr) presenting with
an early infantile epileptic encephalopathy with developmental arrest.
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1 | INTRODUCTION
The Prickle Planar Cell Polarity Protein 1 (PRICKLE1-MIM 608500)
gene is involved in a calcium mediated regulation of planar neuronal
polarity signaling during embryonic development as well as in neuro-
nal morphogenesis, migration, and networking (Bassuk et al., 2008).
PRICKLE1-related phenotypes not only include autosomal reces-
sive progressive myoclonus epilepsy (PME)-ataxia syndrome (MIM
612437) and neural tube defects associated with heterozygous muta-
tions but also agenesis of corpus callosum, polymicrogyria, and autistic
spectrum disorder (Bassuk et al., 2008; Bassuk & Sherr, 2015; Bosoi
et al., 2011; Tao et al., 2011; Todd & Bassuk, 2018). The broad het-
erogeneity of the phenotypic spectrum could be explained by a dos-
age effect involving the encoded protein for patients carrying
heterozygous variants and by the variable degrees of impairment that
may occur in the cascade of signals modulated by PRICKLE1 in the
other cases (Bassuk et al., 2008; Bassuk & Sherr, 2015; Bosoi et al.,
2011; Tao et al., 2011; Todd & Bassuk, 2018).
Early clinical characterization of these rare disorders is limited.
We report on a young boy with a new PRICKLE1 mutation presenting
with early infantile epileptic encephalopathy and reviewed the cases
so far reported in the literature.
2 | CLINICAL REPORT
This 25-month-old boy was born from nonconsanguineous Indian par-
ents after an uneventful pregnancy and labor. Family history
evidenced a single relative in the maternal line with drug-responsive
tonic seizures during childhood. The child’s psychomotor development
before the epilepsy onset was normal.
At the age of 10 months, he manifested prolonged daily clusters
of head-nodding attacks and myoclonic jerks. After the age of
13 months, tonic and focal motor seizures also appeared and progres-
sive developmental delay became apparent (at the age of 14 months
Griffith’s Mental Developmental Scales DQ was less than 50) with
reduced alertness, poor social interactions, and feeding. Despite
ataxia, the child could still walk unsupported at 18 months of age. No
notable dismorphic features or other non-neurological signs and
symptoms were observed. Ictal electroencephalogram (EEG) revealed
generalized delta activity associated with diffuse epileptiform dis-
charges. Interictal EEGs showed multifocal spikes and sharp waves.
Brain magnetic resonance imaging and an extensive neurometabolic
work-up were unremarkable.
Seizures were partially responsive to a combination of adrenocor-
ticotropic hormone (ACTH) (two cycles), valproate, and clonazepam
while other drugs (including phenobarbital, clobazam, pyridoxine, and
vigabatrin) were ineffective.
On the last examination, at 23 months of age, the boy showed
mild ataxia, immature language, hyperactive behavior, and poor eye
contact.
A next generation sequencing panel including 95 genes causing
early infantile epilepsies revealed a novel homozygous missense muta-
tion in the PRICKLE1 gene (NM_153026.2:c.820G>A, p.Ala274Thr).
Both parents were heterozygous carriers of the mutation.
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3 | DISCUSSION
Table 1 summarizes mutational data and clinical characteristics of the
patients with PRICKLE1-related encephalopathy so far reported (Bassuk
et al., 2008; Bassuk & Sherr, 2015; Bosoi et al., 2011; Tao et al., 2011;
Todd & Bassuk, 2018). PME has been reported in 23 subjects with
homozygous variants and in two patients with heterozygous variants
(Table 1; Ehaideb et al., 2014; Paemka et al., 2015; Tao et al., 2011).
A positive neurocognitive outcome and a complete or partial
responsiveness to valproate were reported in almost all cases
(Table 1; Bassuk et al., 2008; Bassuk & Sherr, 2015; Bosoi et al., 2011;
Tao et al., 2011; Todd & Bassuk, 2018). In some patients (patients
4, 7, and 8 in Table 1 and the case reported here) a minor efficacy of
antiepileptic treatment was observed even if no specific phenotypic
feature was highlighted as a reliable predictor for an optimal respon-
siveness (Bassuk et al., 2008; Bassuk & Sherr, 2015; Bosoi et al.,
2011; Tao et al., 2011; Todd & Bassuk, 2018).
The patients so far reported presented a later onset of seizures
(mean age higher than 4 years with the significant exception of
patient 34 in Table 1 who was a 7-month-old male carrying a de novo
mutation and presenting with myoclonic seizures) and a less severe
epilepsy than our patient (Bassuk et al., 2008; Bassuk & Sherr, 2015;
Bosoi et al., 2011; Tao et al., 2011; Todd & Bassuk, 2018).
Epilepsy with pleomorphic seizures and concomitant developmen-
tal arrest suggested the diagnosis of epileptic encephalopathy in our
patient. Seizures-related developmental and cognitive impairment
have not been mentioned as part of the PRICKLE1-related phenotypes
even though a systematic neurodevelopmental evaluation has not
been performed in the previously reported patients (Table 1; Bassuk
et al., 2008; Bassuk & Sherr, 2015; Bosoi et al., 2011; Tao et al., 2011;
Todd & Bassuk, 2018). Variants of PRICKLE1 might contribute to epi-
leptogenesis via various mechanisms such as: (a) impairment of calcium
mediated signaling in different brain regions, especially the cortex,
thalamus, and hippocampus; (b) impairment of microtubule-associated
vesicle transport of neurotransmitters; and (c) dysregulation of neur-
ites’ outgrowth and neuronal connectivity (Bassuk et al., 2008; Ehai-
deb et al., 2014; Todd & Bassuk, 2018).The mutation c.820G>A was
indicated as pathogenic by different in silico prediction softwares
(Mutation Taster, Polyphen 2, and SIFT) and the Combined Annotation
Dependent Depletion (CADD) score was of 31. Three individuals het-
erozygous for this mutation, none homozygous, were present in the
GnomAD database (http://gnomad.broadinstitute.org/). Mutation
Taster and Interpro analysis predicted loss of the third Lin11-Isi1-
Mec3 (LIM) zinc binding domain of the protein. As a consequence of
the p.Ala274Thr transition, the substitution of an alanine residue with
threonine changes the polarized protein distribution that is required
for planar cell polarity signaling. A similar effect was demonstrated in
zebrafish for a mutation involving an adjacent residue (p.Thr275Met),
which had been detected in a patient with neural tube defect and
hydrocephalus but no epilepsy (Bosoi et al., 2011).
The role of PRICKLE1 in different aspects of embryo neurodeve-
lopment would suggest that cognitive and neurological functions can
be impaired as a direct consequence of the defective protein, although
severe epilepsy might have worsened the clinical picture (Bassuk et al.,
2008; Bassuk & Sherr, 2015; Bosoi et al., 2011; Tao et al., 2011).
Moreover, the alterations of neuronal signaling and networking
cascades in which PRICKLE1 is involved may result in dysfunctions of
RE-1 silencing transcription factor or ubiquitin-specific peptidase 9
X-linked, which may as such contribute to the worsening of cognitive
status (Bassuk et al., 2008; Paemka et al., 2015; Todd & Bassuk, 2018).
4 | CONCLUSIONS
This clinical report highlights the fact that in the context of an epilep-
tic encephalopathy with developmental arrest, early onset severe
PME-ataxia syndrome can be a PRICKLE1-associated phenotype.
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